NCT02034578View on ClinicalTrials.gov

Phase 1 Oral Solution Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Healthy Volunteers
Interventions
DRUG

Apixaban

Trial Locations (1)

21225

Parexel Baltimore Early Phase Clinical Unit, Baltimore

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT02034578 - Phase 1 Oral Solution Bioavailability Study of Apixaban When Administered Through a Nasogastric Tube in Healthy Subjects | Biotech Hunter | Biotech Hunter